FOLH1 and xerostomia: In addition, the high kidney and salivary gland uptake of PSMA-targeting radiotherapeutic agents can cause xerostomia and impaired renal function especially when 225Ac-labeled therapeutics such as [225Ac]Ac-PSMA-617 and [225Ac]Ac-PSMA-I&T are used 7, 9.